Junshi licenses COVID-19 antibody tech from Lonza
China’s Junshi Biosciences has licensed technology to produce an antibody against COVID-19 from Swiss biotechnology firm Lonza.
CJEU ‘shuts door’ on SPCs for second medical uses
The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.
LSPN Connect: When IP and COVID-19 meet
The COVID-19 pandemic poses unprecedented challenges to the biomedical community as it strives to find the best solutions to fight COVID-19.
DOJ chief wades into dental antitrust case in rare intervention
The antitrust chief of the US Justice Department (DOJ) made a rare appearance in court when he requested that the US Court of Appeals for the Eleventh Circuit reject a defence used by a medical and dental board against an antitrust lawsuit.
Teva loses TM appeal over ‘French version’ of slogan
Drug company Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the EU General Court ruled in favour of the European Union IP Office (EUIPO) yesterday, July 8.
Roche loses appeal to block market entry of rival cancer drug
A Roche subsidiary will be unable to block Amgen from producing the cancer drug Mvasi (bevacizumab), the Court of Appeals for the Federal Circuit has ruled.
EPO launches ‘Fighting coronavirus’ data platform
The European Patent Office has unveiled data sets relating to antiviral vaccines and pharmaceutical therapeutics as part of its new “Fighting coronavirus” platform.
Australian court affirms Mylan patent invalidation
The Federal Court of Australia has upheld a patent victory for Indian generic manufacturer Sun Pharma over Mylan in a dispute over cholesterol drug fenofibrate.
Federal Circuit rules CardioNet patents 'abstract ideas'
US medical technology company CardioNet has lost an appeal at the US Court of Appeals for the Federal Circuit , which found its patents covered abstract concepts and therefore are invalid.
Carpmaels & Ransford promotes Jennifer Antcliff to partner
European law firm Carpmaels & Ransford has promoted Jennifer Antcliff to partner in its dispute resolution team in its London office, bringing the total number of partners in the team to five.
